Augmentation of immune responses of pelvic lymph node lymphocytes in patients with cervical cancer by sizofiran. - Suppr | 超能文献

Augmentation of immune responses of pelvic lymph node lymphocytes in patients with cervical cancer by sizofiran.

作者信息

Shimizu Y, Chen J T, Hirai Y, Nakayama K, Hamada T, Fujimoto I, Hasumi K, Masubuchi K

机构信息

Department of Gynecology, Cancer Institute Hopital, Tokyo.

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1989 Dec;41(12):2013-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Augmentation of immune responses of pelvic lymph node lymphocytes in patients with cervical cancer by sizofiran.

Nihon Sanka Fujinka Gakkai Zasshi. 1989 Dec;41(12):2013-4.

2

Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer.

Cancer. 1992 Mar 1;69(5):1184-94.

3

Augmentative effect of lentinan on immune responses of pelvic lymph node lymphocytes in patients with uterine cervical cancer.香菇多糖对子宫颈癌患者盆腔淋巴结淋巴细胞免疫反应的增强作用。

Nihon Sanka Fujinka Gakkai Zasshi. 1988 Oct;40(10):1557-8.

4

In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.体内白细胞介素2诱导头颈部肿瘤患者颈淋巴结中淋巴因子激活的杀伤细胞和肿瘤细胞毒性T细胞的活化。

Cancer Res. 1990 Sep 1;50(17):5551-7.

5

[The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell].[从肿瘤引流淋巴结细胞诱导的淋巴因子激活杀伤细胞的特性]

Zhonghua Fu Chan Ke Za Zhi. 1994 Sep;29(9):535-7, 574.

6

Effect of sizofiran on regional lymph nodes in patients with head and neck cancer.

Biotherapy. 1996;9(4):257-62. doi: 10.1007/BF02620739.

7

[Augmentative effect of sizofiran on the immune functions of regional lymph nodes in patients with cervical cancer].[云芝多糖对宫颈癌患者区域淋巴结免疫功能的增强作用]

Nihon Sanka Fujinka Gakkai Zasshi. 1991 Jun;43(6):581-8.

8

[Augmentation of cytotoxicity of regional lymph node lymphocytes of the stomach by in vitro culture in IL2 contained medium].[通过在含白细胞介素2的培养基中进行体外培养增强胃区域淋巴结淋巴细胞的细胞毒性]

Nihon Gan Chiryo Gakkai Shi. 1986 Dec 20;21(10):2411-20.

9

Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.非霍奇金淋巴瘤患者外周血和淋巴结中淋巴因子激活的杀伤细胞的特性分析

Neoplasma. 1993;40(1):15-20.

10

Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.与子宫颈癌患者肿瘤引流淋巴结及外周血中的淋巴细胞相比，肿瘤浸润淋巴细胞含有更多数量的1型细胞因子表达细胞和DR+T细胞。

Gynecol Oncol. 2001 Jun;81(3):424-32. doi: 10.1006/gyno.2001.6200.

引用本文的文献

1

Structural insights into antigen recognition of an anti-β-(1,6)-β-(1,3)-D-glucan antibody.抗β-(1,6)-β-(1,3)-D-葡聚糖抗体的抗原识别结构研究。

Sci Rep. 2018 Sep 12;8(1):13652. doi: 10.1038/s41598-018-31961-x.

2

Generation of Recombinant Antibodies against the beta-(1,6)-Branched beta-(1,3)-D-Glucan Schizophyllan from Immunized Mice via Phage Display.通过噬菌体展示从免疫小鼠中产生抗β-(1,6)-分支β-(1,3)-D-葡聚糖裂褶菌多糖的重组抗体。

Biotechnol Res Int. 2017;2017:8791359. doi: 10.1155/2017/8791359. Epub 2017 May 23.

3

Immunoregulatory effects of sizofiran (SPG) on lymphocytes and polymorphonuclear leukocytes.裂褶菌多糖（SPG）对淋巴细胞和多形核白细胞的免疫调节作用。

Clin Exp Immunol. 1991 Nov;86(2):229-35. doi: 10.1111/j.1365-2249.1991.tb05801.x.